KoBioLabs (348150.KQ) Stock Price

KoBioLabs Price

CLOSED
2,690.00
​
Market closed

Over the last 7 years KoBioLabs grew revenue by 171.2% annually, reaching 69.29 B KRW. For KoBioLabs, the net margin of -9.1% is up versus -531.6% a few years ago.

KoBioLabs stock price

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

KoBioLabs business model & stock analysis

KoBioLabs Inc., headquartered in Seoul, South Korea, operates in the Health Care sector, specializing in biotechnology. The company focuses on research and development of the microbiome, developing products such as Bioviom and Queens henna FOODOLOGY, as well as new microbiome drugs. It provides commissioned research services and sells its products domestically and internationally. Listed on 18 November 2020, KoBioLabs is active in both domestic and overseas markets.

Frequently asked questions about KoBioLabs

Converted at the current exchange rate, the KoBioLabs share trades at 1.82 EUR (2,690.00 KRW).

The revenue cannot currently be calculated for KoBioLabs.

The profit cannot currently be calculated for KoBioLabs.

The P/E ratio cannot be calculated for KoBioLabs at the moment.

The P/S cannot be calculated for KoBioLabs currently.

The Eulerpool Quality Score for KoBioLabs is 4/10.

The ISIN of KoBioLabs is KR7348150004. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.

The ticker of KoBioLabs is 348150.KQ. The ticker symbol is used to trade KoBioLabs shares on the stock exchange.

Fair ValueTerminal
2,286.50 KRW
Over-/UndervaluationTerminal
Fairly valued
Sector
Industry
Biotechnology
Number of shares
Employees
Revenue growth Ø5 years
EBIT growth Ø5 years
Net Income growth Ø5 years
Country
South Korea
Currency
KRW
Initial public offering
Nov 18, 2020
ISIN
KR7348150004
Cusip
Y4S08T103
Market capitalization
51.60 B KRWLarge Cap
52-Week Range
PEG
—
P/E ratio
P/Ee
—
P/S
P/Se
—
EV/EBIT
—
P/B Ratio
1.59
ROE (Return on Equity)
ROA (Return on Assets)
ROCE (Return on Capital Employed)
ROIC (Return on Invested Capital)
-16.30 %
Last updated Nov 16, 2026, 3:44 AM

KoBioLabs Peer Group

KoBioLabs FIGI

348150:KS · BBG00XK2WYN5348150:KQ · BBG00XK2WYQ2

All fundamentals and in-depth analysis of KoBioLabs

Our stock analysis for KoBioLabs stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of KoBioLabs. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.